Hydroxycarbamide Market Type, Application– Trends & Forecasts to 2019-2025
Hydroxycarbamide is a chemotherapy drug used in the treatment of sickle-cell disease, cervical cancer, chronic myelogenous leukemia, and polycythemia vera. It is also known as hydroxyurea and hydrea. It usually comes in the form of capsule and taken by mouth. This drug can also help the patients suffering from chronic myelomonocytic leukemia to live longer. It has the ability to bring the number of white blood cells as well as monocytes back to normal. Manufacturers are trying to enhance the...
View full press release